Senolytics: Cancer Promise vs Epigenetic Limits
Promise: GPX4 inhibitors selectively kill senescent 'zombie' cells via ferroptosis, reducing tumor size and boosting survival in mouse cancer models....

Created by Nathaniel Richardson
AI-driven longevity updates, startup funding, and breakthrough anti-aging therapies
Explore the latest content tracked by Longevity AI Hub
Promise: GPX4 inhibitors selectively kill senescent 'zombie' cells via ferroptosis, reducing tumor size and boosting survival in mouse cancer models....
Stanford's ProtiCelli AI breakthrough visualizes all 13,000 human proteins in a single cell, revealing locations that clue functions—like...
Exciting tool for longevity research:
Boost your brain health with these practical steps from experts:
Non-invasive AI biomarkers from facial photos are advancing personal healthspan monitoring:
Investment surge in AI-healthspan: Wisdom Ventures closed $77.7M Fund II (up from $10M Fund I), backing startups using AI for human resilience,...
Healthspan over lifespan: Tech tackling chronic diseases like heart disease, diabetes, and cancer is crucial, as 9 in 10 older adults have them—aging...
Cell/gene therapy scalability advances via tech, regs, and market shifts:
Game-changer for neurodegeneration: Delivering APOE3 Christchurch gene to the liver via standard vector reduced amyloid plaques, inflammation, and...
Eric Verdin says science to reverse aging is closer than you think, but longevity must balance radical ambition with scientific rigor—or embrace both.
New study uncovers critical mitochondrial-nuclear crosstalk in aging:
Key progress in longevity science:
Precision measurement is the first step in a preventative health revolution, per Steve Horvath ahead of The Longevity Show. The field is converging, if not at consensus.
Emerging trend: Gene therapy strategies are gaining traction for aging intervention and related diseases.
USC student startup turns routine MRIs into predictive biomarkers for early neurodegeneration.
Partial reprogramming uses pulsed Yamanaka factors to restore youthful epigenome function without erasing cell identity.
A large-scale multi-omics study aims to decode aging in Indian populations by identifying biomarkers for resilience, frailty, and age-related decline, while recalibrating biological clocks.
Dr. Junyue Cao's lab at The Rockefeller University develops ultra-high-throughput single-cell technologies and applies them directly to aging biology. A game-changer for decoding healthspan at the cellular level.